Lab Notes: Endo acquires 6 product candidates for $35M; NiKang signs deal worth up to $218M
May 06, 2022 at 12:34 PM EDT
Marinus Pharmaceuticals resumes late-stage testing of its experimental seizure medication.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Copyright 2024. BUSINESS INSURANCE HOLDINGS
